Senores Pharmaceuticals Limited (NSE:SENORES)

Market Cap	28.21B
Revenue (ttm)	3.98B
Net Income (ttm)	585.60M
Shares Out	46.05M
EPS (ttm)	16.12
PE Ratio	37.99
Forward PE	22.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,804
Average Volume	19,289
Open	618.70
Previous Close	612.15
Day's Range	612.75 - 622.00
52-Week Range	440.00 - 664.00
Beta	n/a
RSI	72.68
Earnings Date	Jul 23, 2025

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally. The company offers tablets, capsules, liquids, dry syrups, oral rehydration solutions, active pharmaceutical ingredients, and critical care injectables, including antibiotics, anti-bacterial, anti-fungal, and blood line. It also exports its products. The company provides consulting and licensing services. Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2017
• Employees: 113
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SENORES

Financial Performance

In 2024, Senores Pharmaceuticals's revenue was 3.98 billion, an increase of 85.64% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.17%.